150. HIV: Treatment: Friday, 12:15 - 1:30 p.m.
Poster Session: HIV: Treatment
Benoit Trottier, MD (he/him/his)
HIV Expert
Clinique de medecine urbaine du Quartier Latin
Montreal, Quebec, Canada
Fabrice Bonnet, PhD
CHU de Bordeaux, Hôpital Saint André
Bordeaux, Aquitaine, France
Miguel Garcia-Deltoro, MD, PhD
Concorcio Hospital General Universitario de Valencia
Valencia, Comunidad Valenciana, Spain
Massimo Andreoni, MD
University Tor Vergata
Rome, Lazio, Italy
Marta Boffito, MD, PhD, FRCP
Chelsea and Westminster Hospital NHS Foundation Trust and Imperial College London
London, England, United Kingdom
Berend J. van Welzen, MD, PhD
University Medical Center Utrecht
Utrecht, Utrecht, Netherlands
Dan Turner, MD
Crusaid Kobler AIDS Center, Sackler Faculty of Medicine, Tel Aviv University
Tel Aviv, Tel Aviv, Israel
Sam McConkey, MD, FRCP
RCSI University of Medicine and Health Sciences
Dublin, Dublin, Ireland
Dai Watanabe, MD, PhD
National Hospital Organization Osaka National Hospital
Osaka, Osaka, Japan
Po-Liang Lu, MD, PhD
Kaohsiung Medical University
Kaohsiung, Kaohsiung, Taiwan
Alper Gündüz, MD
Basaksehir Cam and Sakura City Hospital
Istanbul, Istanbul, Turkey
David Thorpe, PhD
Gilead Sciences Europe Ltd
Stockley Park, England, United Kingdom
Michelle L. D’Antoni, PhD
Gilead Sciences, Inc.
Foster City, California, United States
Tali Cassidy, PhD
Gilead Sciences Europe Ltd
Stockley Park, England, United Kingdom
Andrea Marongiu, PhD
Gilead Sciences Europe Ltd
Stockley Park, England, United Kingdom
Amy R. Weinberg, DNP, MS
Gilead Sciences, Inc.
Foster City, California, United States
Richard Haubrich, MD
Vice President
Gilead Sciences
Foster City, California, United States
Stefan Scholten, MD
MD
Medical practice Hohenstaufenring, Cologne, Germany
Köln, Nordrhein-Westfalen, Germany